9 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockers⠀
Class II
Antiarrhythmic Medications ... Classification - Summary Table ... this class are beta ... #Summary #Table ... #pharmacology #
Membrane Actions of Antiarrhythmic Drugs

#Membrane #Channels #Actions #Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table
#Membrane #Channels ... #Actions #Antiarrhythmic ... #Drugs #Medications ... #Pharmacology # ... Cardiology #Table
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Antiarrhythmics ... - Sodium Channel ... Blockers #ClassI #Na #cardiology ... #pharmacology # ... table #comparison
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Antiarrhythmics ... block alpha & beta ... Vaughan #Williams #Pharmacology ... Classification #Classes #pathophysiology ... #cardiology
Antiarrhythmics - Vaughan Williams Classification
Class I (Ia, Ib, Ic) - Na+ Channel Blockade
 • Slows depolarization
Antiarrhythmics ... complex Class II - Beta ... EricsMedicalLectures/ #Antiarrhythmics ... Classification #Classes #cardiology ... #pharmacology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics ... Pharmacology Summary ... block alpha & beta ... #Pharmacology # ... Classification #Classes #pathophysiology
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - ... Pharmacology Comparison ... Table Metoprolol ... #Comparison #Table ... #Receptors #cardiology
Class III Antiarrhythmics - Potassium Channel Blockers - Indications and Side Effects
Amiodarone
 • Suppression of VT
- Potassium Channel ... Blockers - Indications ... a-fib/a-flutter • Rate ... #Blockers #pharmacology ... #cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
increased bleed risk Beta-Blockers ... tachycardia Calcium Channel ... arrhythmias Class I Antiarrhythmic ... supplementals #herbal #pharmacology ... #DDI #table #cardiology